{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:11:46Z","timestamp":1781842306485,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["F4704-B20"],"award-info":[{"award-number":["F4704-B20"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["P32470-B"],"award-info":[{"award-number":["P32470-B"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jaci.2022.04.023","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T18:25:25Z","timestamp":1651343125000},"page":"406-414.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Massive release of TH2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosis"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-0797","authenticated-orcid":false,"given":"Thomas","family":"Boehm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ristl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"M\u00fchlbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wahrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.04.023_bib1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.04.023_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/bja\/65.6.833","article-title":"Massive histamine release in a patient with systemic mastocytosis","volume":"65","author":"Desborough","year":"1990","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaci.2022.04.023_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000329218","article-title":"Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience","volume":"157","author":"Wimazal","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib4","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case\u2013control cohort study of patients\u2019 perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.04.023_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","article-title":"The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions","volume":"2","author":"Jennings","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.04.023_bib6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMcpc1013929","article-title":"Case records of the Massachusetts General Hospital. Case 9-2011. A\u00a037-year-old man with flushing and hypotension","volume":"364","author":"Murali","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.04.023_bib7","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaci.2021.03.043","article-title":"Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis","volume":"148","author":"Boehm","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2022.04.023_bib9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaci.2009.07.055","article-title":"Emergency Department Anaphylaxis Investigators. Elevated serum cytokines during human anaphylaxis: identification of potential mediators of acute allergic reactions","volume":"124","author":"Stone","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/leu.2013.11","article-title":"Increased circulating IL-2R\u03b1 (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2022.04.023_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/all.13663","article-title":"Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients","volume":"74","author":"Boehm","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.04.023_bib12","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.04.023_bib13","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.4049\/jimmunol.168.10.5278","article-title":"IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma","volume":"168","author":"Medoff","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.176.3.781","article-title":"Macrophage inflammatory protein-1 alpha activates basophils and mast cells","volume":"176","author":"Alam","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.04.023_bib15","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.4049\/jimmunol.164.6.3392","article-title":"Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes","volume":"164","author":"Lee","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaci.2022.04.023_bib17","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.1600066","article-title":"IL-10 enhances IgE-mediated mast cell responses and is essential for the development of experimental food allergy in IL-10-deficient mice","volume":"196","author":"Polukort","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0091-6749(97)70078-2","article-title":"Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligation","volume":"99","author":"Bressler","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1165\/ajrcmb.25.6.4541","article-title":"Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge","volume":"25","author":"Hagaman","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.04.023_bib20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.04.023_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1567-5769(02)00235-7","article-title":"Effects of histamine on TH1\/TH2 cytokine balance","volume":"3","author":"Packard","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2022.04.023_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2022.04.023_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molimm.2014.05.007","article-title":"Functional characterization of histamine H4 receptor on human mast cells","volume":"62","author":"Jemima","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/mi.2017.121","article-title":"Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis","volume":"11","author":"Wechsler","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib25","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","article-title":"Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study","volume":"167","author":"Kellum","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2022.04.023_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.04.023_bib27","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2022.04.023_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3899\/jrheum.130466","article-title":"Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan","volume":"41","author":"Koike","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2022.04.023_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","article-title":"GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation","volume":"50","author":"Dougan","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.04.023_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/19420862.2015.1119352","article-title":"CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common \u03b2 chain of the IL-3, GM-CSF and IL-5 receptors","volume":"8","author":"Panousis","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2022.04.023_bib31","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fphar.2019.01387","article-title":"The intriguing role of interleukin 13 in the pathophysiology of asthma","volume":"10","author":"Marone","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2022.04.023_bib32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/ajrccm.156.5.9610064","article-title":"Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge","volume":"156","author":"Holgate","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.04.023_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM200102013440507","volume":"344","author":"Busse","year":"2001","journal-title":"Asthma. N Engl J Med"},{"key":"10.1016\/j.jaci.2022.04.023_bib34","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI200113930","article-title":"Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization","volume":"108","author":"Mazzoni","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.04.023_bib35","doi-asserted-by":"crossref","unstructured":"Desai P, Thurmond RL. Histamine H\u2084 receptor activation enhances LPS-induced IL-6 production in mast cells via ERK and PI3K activation. Eur J Immunol 2011;41:1764-1773.","DOI":"10.1002\/eji.201040932"},{"key":"10.1016\/j.jaci.2022.04.023_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2005.12.052","article-title":"Corticosteroids: the drugs to beat","volume":"533","author":"Barnes","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2022.04.023_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68542","article-title":"Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical","volume":"10","author":"Gludovacz","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jaci.2022.04.023_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jaci.2022.04.023_bib39","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaci.2021.03.043","article-title":"Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis","volume":"148","author":"Boehm","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"72","key":"10.1016\/j.jaci.2022.04.023_bib40","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1046\/j.1523-1755.56.s72.14.x","article-title":"Is cytokine removal by continuous hemofiltration feasible?","author":"Sieberth","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jaci.2022.04.023_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01980899","article-title":"Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects","volume":"32","author":"Pollock","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaci.2022.04.023_bib42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1567-5769(02)00235-7","article-title":"Effects of histamine on TH1\/TH2 cytokine balance","volume":"3","author":"Packard","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2022.04.023_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01973821","article-title":"Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: fact or fictions?","volume":"14","author":"Hesterberg","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaci.2022.04.023_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1067\/mai.2001.113080","article-title":"Skin concentrations of H1-receptor antagonists","volume":"107","author":"Simons","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mai.2002.129123","article-title":"Clinical pharmacology of H1-antihistamines in the skin","volume":"110","author":"Simons","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.023_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922006170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922006170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:38:24Z","timestamp":1758793104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922006170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0091674922006170"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.04.023","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Massive release of TH2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}